Ritonavir

Product NDC

60687-364

11-digit product format

606870364

Labeler code

60687

Product ID

60687-364_82824416-80a1-76bd-e053-2a91aa0ad8b5

Type

HUMAN PRESCRIPTION DRUG

Nonproprietary name

Ritonavir

Dosage form

TABLET, FILM COATED

Route

ORAL

Labeler

American Health Packaging

Application

ANDA202573

Marketing category

ANDA

Marketing start

2018-05-01

Marketing end

2019-10-31

Substance

RITONAVIR

Active strength

100 mg/1

Pharmacologic classes

HIV Protease Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],UDP Glucuronosyltransferases Inducers [MoA]

NDC exclude flag

No

Listing certified through

0000-00-00

Current FDA listing

Historical FDA.report record